Reuters logo
3 years ago
BRIEF-Teva CEO says company must regain focus on generics business
May 1, 2014 / 12:55 PM / 3 years ago

BRIEF-Teva CEO says company must regain focus on generics business

May 1 (Reuters) - Teva Pharmaceutical Industries' new chief executive, Erez Vigodman, says:

* Company must regain focus on generics business

* Will be considering "inorganic opportunities" in biosimilars sector

* Company will start expanding in emerging markets

* Aware of M&A opportunities including potential larger transactions

* Any company launching generic Copaxone "at-risk" faces exposure in the billions of dollars

* FDA should require clinical trials of companies seeking to launch generic Copaxone (Reporting by Tova Cohen and Steven Scheer)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below